Ninety One’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5M Buy
13,721
+12,101
+747% +$12.4M 0.89% 18
2026
Q1
$1.48M Buy
1,620
+1,020
+170% +$1.03M 0.06% 65
2025
Q4
$645K Hold
600
0.03% 67
2025
Q3
$437K Hold
600
0.02% 79
2025
Q2
$468K Sell
600
-28
-4% -$21.8K 0.08% 60
2025
Q1
$506K Buy
628
+340
+118% +$283K 0.09% 54
2024
Q4
$222K Buy
+288
New +$238K 0.05% 72
2023
Q4
Sell
-14,579
Closed -$7.85M 75
2023
Q3
$7.85M Buy
+14,579
New +$7.51M 1.52% 24
2020
Q1
Sell
-387
Closed -$44K 126
2019
Q4
$44K Hold
387
0.02% 102
2019
Q3
$44K Hold
387
0.02% 102
2019
Q2
$43K Sell
387
-299
-44% -$35.2K 0.02% 102
2019
Q1
$89K Sell
686
-95
-12% -$11.6K 0.05% 89
2018
Q4
$90K Sell
781
-54,496
-99% -$6.09M 0.05% 92
2018
Q3
$5.94M Sell
55,277
-18,417
-25% -$1.84M 0.97% 26
2018
Q2
$6.29M Buy
73,694
+73,183
+14,322% +$6.01M 0.85% 34
2018
Q1
$39K Hold
511
0.02% 98
2017
Q4
$44K Buy
+511
New +$43.5K 0.02% 75

Other funds holding LLY

Ninety One's LLY Position: Q2 2026 in Review

Ninety One increased its Eli Lilly (LLY) stake by 747% in Q2 2026, buying an estimated $12.4M and bringing the position to 13,721 shares worth $16.5M. The position accounts for 0.89% of the portfolio, ranked #18.

Ninety One first reported a position in LLY in Q4 2017 and has held it in 17 quarters since. 2,244 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ninety One held 13,721 shares of Eli Lilly worth $16.5M as of Q2 2026.
  • Ninety One bought 12,101 Eli Lilly shares in Q2 2026, an estimated $12.4M.
  • Eli Lilly made up 0.89% of Ninety One's portfolio in Q2 2026, its #18 holding.
  • Ninety One first reported a position in Eli Lilly in Q4 2017 and has held it in 17 quarters since.
  • 2,244 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ninety One's 13F filing for Q2 2026, filed 16 Jul 2026.